311 related articles for article (PubMed ID: 33012018)
41. The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer.
Arriaga-Canon C; Contreras-Espinosa L; Aguilar-Villanueva S; Bargalló-Rocha E; García-Gordillo JA; Cabrera-Galeana P; Castro-Hernández C; Jiménez-Trejo F; Herrera LA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108589
[TBL] [Abstract][Full Text] [Related]
42. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
43. Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus.
Saeidi L; Ghaedi H; Sadatamini M; Vahabpour R; Rahimipour A; Shanaki M; Mansoori Z; Kazerouni F
Mol Biol Rep; 2018 Dec; 45(6):2601-2608. PubMed ID: 30328000
[TBL] [Abstract][Full Text] [Related]
44. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
45. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
Tantai J; Hu D; Yang Y; Geng J
Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
[TBL] [Abstract][Full Text] [Related]
46. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
47. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA MIF-AS1 promotes breast cancer cell proliferation, migration and EMT process through regulating miR-1249-3p/HOXB8 axis.
Ding J; Wu W; Yang J; Wu M
Pathol Res Pract; 2019 Jul; 215(7):152376. PubMed ID: 31097355
[TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.
Lu C; Wang X; Zhao X; Xin Y; Liu C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32110804
[TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
51. Expression analysis of vimentin and the related lncRNA network in breast cancer.
Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
[TBL] [Abstract][Full Text] [Related]
52. Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis.
Xue S; Guo H; Wei S; Song Y; Huang J; Deng S; Li Q; Li W
Transl Androl Urol; 2022 Sep; 11(9):1304-1317. PubMed ID: 36217399
[TBL] [Abstract][Full Text] [Related]
53. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
54. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
55. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
56. A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify
Shen D; Zhang Y; Zheng Q; Yu S; Xia L; Cheng S; Li G
DNA Cell Biol; 2021 Jan; 40(1):26-35. PubMed ID: 33270518
[TBL] [Abstract][Full Text] [Related]
57. Long non-coding RNA DSCAM-AS1 upregulates
Zhang S; Ding L; Gao F; Fan H
Biochem Cell Biol; 2020 Oct; 98(5):600-611. PubMed ID: 32379981
[TBL] [Abstract][Full Text] [Related]
58. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.
Zheng QX; Wang J; Gu XY; Huang CH; Chen C; Hong M; Chen Z
Biomed Pharmacother; 2021 Mar; 135():111169. PubMed ID: 33433359
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer.
Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873
[TBL] [Abstract][Full Text] [Related]
60. Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer.
Yadav N; Sunder R; Desai S; Dharavath B; Chandrani P; Godbole M; Dutt A
Breast Cancer Res; 2022 Dec; 24(1):97. PubMed ID: 36578092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
